A fast reverse-phase high performance liquid chromatographic tandem mass spectrometry assay for the quantification of clindamycin in plasma and saliva using a rapid resolution package

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 4, 2009, Pages 649-654

  Catena, Esther ^a   Perez, Guiomar ^a   Sadaba, Belen ^a   Azanza, Jose Ramón ^a   Campanero, Miguel Angel ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Clindamycin; Pharmacokinetics; Saliva; Therapeutic drug monitoring

Indexed keywords

CLINDAMYCIN; LINCOMYCIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG SALIVA LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINDAMYCIN; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SALIVA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 67849109992     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.02.005     Document Type: Article

References (18)

1. Bartlett J.G., Breiman R.F., Mandell L.A., and File T.M. Clin. Infect. Dis. 26 (1998) 811-838
2. Guay D. Expert. Opin. Pharmacother. 8 (2007) 2401-2444
3. DeHaan R.M., Metzler C.M., Schellenberg D., VandenBosch W.D., and Masson E.L. Int. J. Clin. Pharmacol. 6 (1972) 105-119
4. Metzler C.M., DeHaan R., Schellenberg D., and Vandenbosch W.D. J. Pharm. Sci. 62 (1973) 591-598
5. Wynalda M.A., Hutzler J.M., Koets M.D., Podoll T., and Wienkers L.C. Drug Metab. Dispos. 31 (2003) 878-887
6. Craig W.A. Clin. Infect. Dis. 33 Suppl. 3 (2001) S233-237
7. Duckworth C., Fisher J.F., Carter S.A., Newman C.L., Cogburn C., Nesbit R.R., and Wray C.H. J. Antimicrob. Chemother. 31 (1993) 581-584
8. Gatti G., Flaherty J., Bubp J., White J., Borin M., and Gambertoglio J. J. Antimicrob. Chemother. 37 (1993) 1137-1143
9. Na-Bangchang K., Banmairuroi V., Kamanikom B., and Kiod D. Southeast Asian J. Trop. Med. Public Health 37 (2006) 177-184
10. Cho S.H., Im H.T., Park W.S., Ha Y.H., Choi Y.W., and Lee K.T. Biomed. Chromatogr. 19 (2005) 783-787
11. Fieger-Büschges H., Schüssler G., Larsimont V., and Blume H. J. Chromatogr. B: Biomed. Sci. Appl. 724 (1999) 281-286
12. Liu C.M., Chen Y.K., Yang T.H., Hsieh S.Y., Hung M.H., and Lin E.T. J. Chromatogr. B: Biomed. Sci. Appl. 696 (1997) 298-302
13. La Follette G., Gambertoglio J., White J.A., Knuth D.W., and Lin E.T. J. Chromatogr. 431 (1988) 379-488
14. Yu L.L., Chao C.K., Liao W.J., Twu T.Y., Liu C.M., Yang T.H., and Lin E.T. J. Chromatogr. B: Biomed. Sci. Appl. 724 (1999) 287-294
15. Martens-Lobenhoffer J., and Banditt P. J. Chromatogr. B: Biomed. Sci. Appl. 755 (2001) 143-149
16. Cherlet M., Croubels S., and De Backer P. J. Mass Spectrom. 37 (2002) 848-853
17. Rechberger G.N., Fauler G., Windischhofer W., Köfeler H., Erwa W., and Leis H.J. Rapid Commun. Mass Spectrom. 17 (2003) 135-139
18. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May, 2001.